Results 41 to 50 of about 15,233 (195)

Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31. [PDF]

, 2020
Lyme disease is one of most common vector-borne diseases, reporting more than 300,000 cases annually in the United States. Treating Lyme disease during its initial stages with traditional tetracycline antibiotics is effective. However, 10-20% of patients
Ahmed, Mohamed Sohail, Ambati, Aditya, Inayathullah, Mohammed, Mallajosyula, Venkata Vamsee Aditya, Pothineni, Venkata Raveendra, Potula, Hari-Hara SK, Rajadas, Jayakumar, Sridharan, Brindha   +7 more
core  

Cross-Sectional Study Evaluating the Role of Autonomic Nervous System Functional Diagnostics in Differentiating Post-Infectious Syndromes: Post-COVID Syndrome, Chronic Fatigue Syndrome, and Lyme Disease

Biomedicines
Background/Objectives: Post-infectious syndromes, including Post-COVID syndrome, Chronic Fatigue Syndrome, and late-stage Lyme disease, are associated with overlapping clinical features and autonomic dysfunction.
Branislav Milovanovic, Nikola Markovic, Masa Petrovic, Vasko Zugic, Milijana Ostojic, Milovan Bojic   +5 more
doaj   +1 more source

Exacerbation of chronic pain after dental extractions in a patient with post-treatment Lyme disease syndrome

Saudi Journal of Anaesthesia, 2018
A subset of patients who had Lyme disease experience postinfectious signs or symptoms called post-treatment Lyme disease syndrome (PTLDS). PTLDS is a chronic condition including pain in joints and muscles, neurological symptoms including demyelinating ...
Stephanie Lim, Sakura Kinjo
doaj   +1 more source

Management of pediatric uveitis [PDF]

, 2014
Pediatric uveitis is a topic of special interest not only because of the unique diagnostic and therapeutic challenges but also because of the lifetime burden of vision loss if the problem is not adequately treated, as well as the economic and ...
Foster, C. Stephen, Freitas-Neto, Clovis A., Wentworth, Bailey A.   +2 more
core   +1 more source

Health care costs, utilization and patterns of care following Lyme disease.

PLoS ONE, 2015
BackgroundLyme disease is the most frequently reported vector borne infection in the United States. The Centers for Disease Control have estimated that approximately 10% to 20% of individuals may experience Post-Treatment Lyme Disease Syndrome - a set of
Emily R Adrion, John Aucott, Klaus W Lemke, Jonathan P Weiner   +3 more
doaj   +1 more source

Severity of chronic Lyme disease compared to other chronic conditions: a quality of life survey [PDF]

, 2014
Overview. The Centers for Disease Control and Prevention (CDC) health-related quality of life (HRQoL) indicators are widely used in the general population to determine the burden of disease, identify health needs, and direct public health policy.
Aslan, Aucott, Aucott, Bayliss, Becker, Bhinder, Boscardin, Burns, Cairns, Cameron, Centers for Disease Control and Prevention, Chandra, Cook, DeSalvo, Donkin, Fallon, Hoge, Institute of Medicine, Johnson, Klempner, Lackner, Liu, Logigian, Moriarty, Rangnekar, Richardson, Schutzer, Shadick, Smith, Steere, Stricker, Toossi, van Gelder, Wolfe, Yazdany   +34 more
core   +1 more source

Lyme Disease

Journal of Microbiology and Infectious Diseases, 2014
Lyme disease (LD) is caused by the spirochete, Borrelia burgdorferi sensu lato complex. Humans are infected by a tick bite to the skin. This disease is a non-contagious infectious disease. It has been known since the 19th century.
Davut Ozdemir, Nevin İnce
doaj   +1 more source

Cellular immune response of Amblyomma sculptum and Amblyomma americanum to entomopathogenic fungi: Implications for biological tick control

Medical and Veterinary Entomology, EarlyView.
Amblyomma sculptum showed a plasmatocyte‐dominant haemocyte profile. Beauveria bassiana increased plasmatocytes and reduced granulocytes, whereas Metarhizium robertsii did not cause significant changes. Amblyomma americanum showed a granulocyte‐dominant haemocyte profile. Beauveria bassiana reduced total haemocytes and granulocytes. B.
Cárita de Souza Ribeiro‐Silva, Valesca Henrique Lima, Salorrane Miranda N. Pinto, Gustavo Felizardo S. Sandes, Victor Hugo Ribeiro Costa, Albert Mulenga, Adela S. Oliva Chavez, Éverton Kort Kamp Fernandes   +7 more
wiley   +1 more source

Risk Factors and Outcomes of Treatment Delays in Lyme Disease: A Population-Based Retrospective Cohort Study

Frontiers in Medicine, 2020
Background: Longer time between symptom onset and treatment of Lyme disease has been associated with poor outcomes. Reducing time-to-treatment requires knowledge of risks for treatment delays.
Annemarie G. Hirsch, Melissa N. Poulsen, Cara Nordberg, Katherine A. Moon, Alison W. Rebman, John N. Aucott, Christopher D. Heaney, Christopher D. Heaney, Christopher D. Heaney, Brian S. Schwartz, Brian S. Schwartz   +10 more
doaj   +1 more source

Education on Tickborne Diseases and Prevention Strategies [PDF]

, 2017
Research suggests that around 300,000 people are diagnosed with Lyme disease each year and that around one billion dollars is spent on healthcare for Lyme disease alone.
Bernard, Christopher
core   +1 more source